PAPER Simoes S, Neufeld JL, Triana-Baltzer G, Moughadam S, Chen EI, Kothiya M, Qureshi YH, Patel V, Honig LS, Kolb H, Small SA
SEARCH RESULTS
18740 RESULTS
PAPER Phongpreecha T, Fernandez R, Mrdjen D, Culos A, Gajera CR, Wawro AM, Stanley N, Gaudilliere B, Poston KL, Aghaeepour N, Montine TJ
Single-cell peripheral immunoprofiling of Alzheimer's and Parkinson's diseases.
Sci Adv. 2020 Nov;6(48) Print 2020 Nov PubMed: 33239300PAPER Doorduijn AS, de van der Schueren MA, van de Rest O, de Leeuw FA, Hendriksen HM, Teunissen CE, Scheltens P, van der Flier WM, Visser M
Nutritional Status Is Associated With Clinical Progression in Alzheimer's Disease: The NUDAD Project.
J Am Med Dir Assoc. 2020 Nov 15; PubMed: 33239240PAPER Saini P, Rudakou U, Yu E, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Fahn S, Waters C, Monchi O, Dauvilliers Y, Dupré N, Greenbaum L, Hassin-Baer S, Espay AJ, Rouleau GA, Alcalay RN, Fon EA, Postuma RB, Gan-Or Z
Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.
Neurobiol Aging. 2021 Apr;100:119.e7-119.e13. Epub 2020 Oct 31 PubMed: 33239198PAPER Kwon HS, Koh SH
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
Transl Neurodegener. 2020 Nov 26;9(1):42. PubMed: 33239064PAPER Schartz ND, Tenner AJ
The good, the bad, and the opportunities of the complement system in neurodegenerative disease.
J Neuroinflammation. 2020 Nov 25;17(1):354. PubMed: 33239010PAPER Benson C, Friz A, Mullen S, Block L, Gilmore-Bykovskyi A
Ethical and Methodological Considerations for Evaluating Participant Views on Alzheimer's and Dementia Research.
J Empir Res Hum Res Ethics. 2021 Feb-Apr;16(1-2):88-104. Epub 2020 Nov 26 PubMed: 33238781PAPER Liu J, Cao ZY
[Roles of amyloid-β in the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease should be clarified].
Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3385-3387. PubMed: 33238667PAPER Snow WM, Cadonic C, Cortes-Perez C, Adlimoghaddam A, Roy Chowdhury SK, Thomson E, Anozie A, Bernstein MJ, Gough K, Fernyhough P, Suh M, Albensi BC
Sex-Specific Effects of Chronic Creatine Supplementation on Hippocampal-Mediated Spatial Cognition in the 3xTg Mouse Model of Alzheimer's Disease.
Nutrients. 2020 Nov 23;12(11) PubMed: 33238473PAPER Gireud-Goss M, Mack AF, McCullough LD, Urayama A
Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction.
Neuroscientist. 2020 Nov 25;:1073858420954811. PubMed: 33238806PAPER Chen HM, Zhang MM, Wang YL
[Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3397-3401. PubMed: 33238668PAPER Palermo F, Pieroni N, Maugeri L, Provinciali GB, Sanna A, Massimi L, Catalano M, Olbinado MP, Bukreeva I, Fratini M, Uccelli A, Gigli G, Kerlero de Rosbo N, Balducci C, Cedola A
X-ray Phase Contrast Tomography Serves Preclinical Investigation of Neurodegenerative Diseases.
Front Neurosci. 2020;14:584161. Epub 2020 Nov 9 PubMed: 33240038PAPER Ridler T, Witton J, Phillips KG, Randall AD, Brown JT
Impaired speed encoding and grid cell periodicity in a mouse model of tauopathy.
Elife. 2020 Nov 26;9 PubMed: 33242304Targeting Protein Misfolding Congress 2021
CONFERENCE 2021-03-15 00:00:00-2021-03-17 00:00:00 Online Meeting 15 March 2021 to 17 March 2021 View Conference Website 0
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) (PAR-20-309)
GRANT Friday, November 27, 2020- 10:00am National Institute on Aging Standard dates apply. The first standard due date for this FOA is February 5, 2021. https://grants.nih.gov/grants/guide/pa-files/PAR-20-309.html 08 May 2024
Current Filters
- Date Range : Nov 2019 to Nov 2020 x